• TR4 fungus detected in Ecuador, top global banana exporter
• No cure exists; Cavendish variety faces major threat
• Industry under pressure, rising costs push toward diversification
  

In late September 2025, Ecuador announced it had detected the “tropical race 4” (TR4) strain of Panama disease, sending alarm through the global banana industry. As the world’s top banana exporter—shipping nearly six million metric tons in 2023, about one-third of global trade—the country’s health alert has heightened concern at home and abroad over potential disruptions to the trade in the world’s most widely eaten fruit.

A Persistent and Spreading Threat

TR4 is the fourth strain of the Fusarium fungus, which lives in the soil and chokes banana plants by preventing them from absorbing nutrients. First identified in Taiwan in 1970, the strain now attacks a wider range of dessert bananas and plantains. It spreads through contaminated planting material, soil, irrigation water, and even footwear and tools.

Altus Viljoen, a plant pathologist at Stellenbosch University in South Africa and one of the world’s leading experts on the disease, said symptoms take time to appear. “Once the fungus is introduced into a banana field, symptoms can take 6-24 months to develop before the disease becomes visible. During this time, the pathogen spreads in the soil and water, without people being aware that it is there,” he explained.

Denis Loeillet, a researcher at the French agricultural research center CIRAD, added that the banana plant’s defense mechanism “blocks its own vessels and eventually dies. This can take anywhere from a few months to a few years.”

Global Spread and Economic Consequences

Ecuador’s detection makes it the latest major fruit exporter affected, following cases in the Philippines—the world’s second-largest banana exporter—in 2005 and Colombia, the fifth-largest, in 2019. The disease now affects more than 20 producing countries, including Australia, China, Laos, Cambodia, Venezuela, Peru, Vietnam, Myanmar, Thailand, and India. In Africa, TR4 was first reported in northern Mozambique in 2013.

The global banana industry regards the development as serious. The Food and Agriculture Organization (FAO) describes TR4 as one of the world’s most destructive plant diseases, capable of wiping out entire harvests.

No effective fungicide or eradication method currently exists. The only defense is strict biosecurity to prevent the fungus from entering plantations. Once present, management becomes costly and complex.

“When a banana plant is infected, for example in the Philippines, farmers uproot the pseudostem and root, apply chemical treatments, and clear a buffer zone around the affected area. You can live with the disease for a while, but productivity falls. In the end, you have to relocate the plantation,”  Loeillet told Ecofin Agency in 2020.

Cavendish Variety at Risk

A deeper concern is the vulnerability of the ‘Cavendish’ banana, which represents about 95% of global exports and half of world production. Experts fear it could face the same fate as the now-extinct ‘Gros Michel’ variety, which dominated international markets in the 1950s before being wiped out by an earlier strain of Panama disease (TR1).

While it is too early to predict such an outcome, the industry’s current structure—where cultivation systems, packaging, logistics, and ripening are all standardized around the seedless, sterile Cavendish—makes the sector highly exposed to pests and pathogens.

Market Pressures and Future Outlook

Ecuador’s outbreak adds to the banana industry’s mounting challenges. During the COVID-19 pandemic in 2020, producers faced surging costs for fertilizers and packaging materials, a shortage of refrigerated containers, and rising transport expenses. Since then, extreme weather has worsened the spread of plant diseases and reduced yields.

Bananas remain the world’s cheapest fruit, but maintaining this affordability may become increasingly difficult as production losses mount and the cost of TR4 prevention rises. Producers are already calling for higher prices to ensure minimum profit margins, allowing reinvestment in farms and a shift toward more sustainable production systems.

Another avenue under study is the development of new varieties through crossbreeding or genetic modification. The global banana gene pool includes more than 1,000 varieties.

“Daring to change variety would call into question decades of knowledge and habits,” noted Fruitrop, CIRAD’s tropical fruit review, in its November 2019 issue. “The market abhors technological breakthroughs, unless forced on by regulations, technical immobilisation, diseases or demand. The expansion of the TR4 disease provides grounds to believe that diversification is the necessary way forward.”

Espoir Olodo